Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2005
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1285065B1 Long wavelength engineered fluorescent proteins
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1141245B1 Somatic cells with ablated prp gene and methods of use
11/09/2005EP1111048B1 Neutral amino acid transporter and gene thereof
11/09/2005EP0960192B1 Synthetic polynucleotides
11/09/2005EP0950068B1 Collagen binding protein compositions and methods of use
11/09/2005EP0910644B1 Retinoid metabolizing protein
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
11/09/2005EP0842278B1 Dnase-active protein
11/09/2005EP0812359B1 Group o hiv-1, fragments of such viruses, and uses thereof
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005EP0769149B1 Immunoassay for mycophenolic acid
11/09/2005EP0760857B1 Receptor for oncostatin m
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005EP0719330B1 Protocadherin proteins and their uses
11/09/2005CN1695059A Method of diagnosing colon and gastric cancers
11/09/2005CN1694902A Methods for regulating cancer
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694894A Anti-IL-6 antibodies, compositions, methods and uses
11/09/2005CN1694490A Method, equipment and computer program of changed digital color image
11/09/2005CN1226413C Trichina TS88 gene, their protein products and uses
11/09/2005CN1226410C CR1 gene related to cell reconstitution, conduction and death
11/09/2005CN1226306C Antibodies to placental protein 13
11/09/2005CN1226046C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor and pharmaceutical compositions containing same
11/08/2005US6962988 Comprises deiminase polypeptide for sterilization of female animals and/or the generation of antibodies useful for temporary, reversible contraception
11/08/2005US6962981 denaturing-free; for immunoassay; for diagnosis/treatment of cancer
11/08/2005US6962980 Stimulant immunology response; polynucleotides
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962976 Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole
11/08/2005US6962972 Active material; denaturing protein; hybrid enzyme
11/08/2005US6962969 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/08/2005US6962903 Modified annexin proteins and methods for preventing thrombosis
11/08/2005US6962813 P. aeruginosa mucoid exopolysaccharide specific binding peptides
11/08/2005US6962801 Protein for blocking platelet adhesion
11/08/2005US6962799 Microtubule-associated proteins and tubulins
11/08/2005US6962795 Neutrophil inhibitors
11/08/2005US6962787 Diagnostic method for a transmissible spongiform encephalopathy or a prion disease
11/08/2005US6962707 Therapeutic agent comprising immunogenic, natural A beta peptide with adjuvant alum to enhance the immune response; conjugated A beta fragment with carrier T cell epitope; Alzheimer's disease
11/08/2005US6962706 for use in raising immune response against Porphyromonas gingivalis, comprising suitable adjuvant, carrier or excipient and peptide of not more than 50 amino acids including P. gingivalis epitope comprising sequence RYDDFTFEAGKKYTFTMRRAGMGDGTD
11/08/2005US6962702 Diagnosis of tissue damage, cancer
11/08/2005US6962701 Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
11/08/2005US6962700 concentrating raw immunoglobulin solution; freezing; thawing, adding sufficient mono or disaccharide to thawed concentrated immunoglobulin solution to yield a solution of 0.25 to 0.35 osmolar, filtering, lyophilizing
11/08/2005US6962694 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
11/08/2005CA2293401C A method for depleting viral and molecular pathogens in a biological material
11/03/2005WO2005103698A2 Methods and antibodies for nitrofuran detection
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103257A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
11/03/2005WO2005103256A1 Gene encoding gtpase activating protein and gene product thereof
11/03/2005WO2005103250A1 THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
11/03/2005WO2005103243A2 Carboxypeptidases b from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets
11/03/2005WO2005103240A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1)
11/03/2005WO2005103088A1 A single-domain antibody strengthening fusion protein vh-ldp-ae
11/03/2005WO2005103086A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
11/03/2005WO2005103085A1 A diabody which specifically binds streptococcus surface antigen i/ii and methods of use thereof
11/03/2005WO2005103084A2 Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
11/03/2005WO2005103083A2 Anti-cd38 human antibodies and uses therefor
11/03/2005WO2005103081A2 Human monoclonal antibodies against cd20
11/03/2005WO2005102938A2 Antibodies specific for bcr-abl fusion protein and uses thereof
11/03/2005WO2005102387A2 Therapeutic use of anti-cs1 antibodies
11/03/2005WO2005102386A1 Treatment of fungal infections
11/03/2005WO2005066363A3 Cancer specific gene ccndbp1
11/03/2005WO2005066211A3 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
11/03/2005WO2005060713A3 Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions
11/03/2005WO2005058961A3 Antibodies specific for human galanin, and uses thereof
11/03/2005WO2005055936A3 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
11/03/2005WO2005051295A3 Asymmetrically branched polymer conjugates and microarray assays
11/03/2005WO2005047331A3 Antibodies that bind interleukin-4 receptor
11/03/2005WO2005047327A8 NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
11/03/2005WO2005046657A3 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease
11/03/2005WO2005046597A3 Antibodies to cd44 glycoforms and uses thereof
11/03/2005WO2005044998A3 Enhanced b cell cytotoxicity of cdim binding antibody
11/03/2005WO2005020927A3 Method of promoting graft survival with anti-tissue factor antibodies
11/03/2005WO2005019831B1 Methods for reducing complexity of a sample using small epitope antibodies
11/03/2005WO2005010485A3 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials
11/03/2005WO2005009396A3 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/03/2005WO2005007696A3 Humanized immunoglobulin loci
11/03/2005WO2003074551A8 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
11/03/2005WO2003000842A3 Novel proteins and nucleic acids encoding same
11/03/2005US20050246782 Transgenic aves producing human polyclonal antibodies
11/03/2005US20050245731 DNA encoding tumor necrosis factor inhibitory protein and its use
11/03/2005US20050245730 Wound healing agents; anticancer agents; cardiovascular disorders; immunostimulants
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050244969 Transient immortalization
11/03/2005US20050244929 Expression of functional antibody fragments
11/03/2005US20050244927 Process for producing polypeptides
11/03/2005US20050244906 Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and process for producing the same
11/03/2005US20050244901 Polynucleotide with a sequence coding for a fusion protein that is an anti-fungal protein or peptide and an antibody FV fragment specifically recognising an epitope of an Ascomyceta, and a cellular targeting signal
11/03/2005US20050244900 Glycine N-methyltransferase monoclonal antibodies and methods of use therefor
11/03/2005US20050244899 Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244876 Human tumor necrosis factor receptors TR13 and TR14
11/03/2005US20050244868 Ten-M3 polypeptides and polynucleotides and their methods of use
11/03/2005US20050244867 Growth factor HTTER36
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244857 Death domain containing receptor 4
11/03/2005US20050244856 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
11/03/2005US20050244852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/03/2005US20050244844 serine/threonine phosphatases (PP1); immobilization, screening
1 ... 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 ... 1494